Utilization of molecular genetic approaches for colorectal cancer screening

被引:1
作者
Emelyanova, Marina A. [1 ]
Ikonnikova, Anna Y. [1 ]
机构
[1] Russian Acad Sci, Engelhardt Inst Mol Biol, Ctr Precis Genome Editing & Genet Technol Biomed, 32 Vavilov St, Moscow 119991, Russia
关键词
Colorectal cancer; Cancer screening; Non-invasive screening; Liquid biopsy; Polygenic risk score; MULTITARGET STOOL DNA; COLONOSCOPY; EXPRESSION; BIOMARKERS;
D O I
10.3748/wjg.v30.i46.4950
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The feasibility of population screening for colorectal cancer has been demonstrated in several studies. Most of these studies have considered individual characteristics, diagnostic approaches, epidemiological data, and socioeconomic factors. In this article, we comment on an editorial by Metaxas et al published in the recent issue of the journal. The authors emphasized the need to raise public awareness through health education programs and the possibility of using easily accessible non-invasive screening methods. Here, we focus on non-invasive molecular genetic approaches that can aid in colorectal cancer screening. On the one hand, we highlighted the use of tumor DNA/RNA markers directly for screening and, on the other hand, underline the use of polygenic risk assessment and hereditary predisposition to select individuals for more thorough cancer screening.
引用
收藏
页码:4950 / 4957
页数:9
相关论文
共 67 条
[1]   Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany [J].
Adler, Andreas ;
Geiger, Sebastian ;
Keil, Anne ;
Bias, Harald ;
Schatz, Philipp ;
deVos, Theo ;
Dhein, Jens ;
Zimmermann, Mathias ;
Tauber, Rudolf ;
Wiedenmann, Bertram .
BMC GASTROENTEROLOGY, 2014, 14 :1-8
[2]  
[Anonymous], COLORECTAL SCREENING ACROSS EUROPE. Vienna
[3]  
[Anonymous], 2021, Prevention of Colorectal Cancer Through Multiomics Blood Testing. (PREEMPT CRC) ClinicalTrials.gov Identifier: NCT04369053
[4]  
[Anonymous], Colorectal Cancer Risk Factors
[5]   Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics [J].
Bareja, Chanchal ;
Dwivedi, Kountay ;
Uboveja, Apoorva ;
Mathur, Ankit ;
Kumar, Naveen ;
Saluja, Daman .
SCIENTIFIC REPORTS, 2024, 14 (01)
[6]  
Barnell EK, 2023, JAMA-J AM MED ASSOC, V330, P1760, DOI [10.3322/caac.v73.1, 10.1001/jama.2023.22231]
[7]   Multitarget stool DNA for colorectal cancer screening: A review and commentary on the United States Preventive Services Draft Guidelines [J].
Berger, Barry M. ;
Levin, Bernard ;
Hilsden, Robert J. .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 8 (05) :450-458
[8]   High accuracy of a blood ctDNA-based multimodal test to detect colorectal cancer [J].
Bessa, X. ;
Vidal, J. ;
Balboa, J. C. ;
Marquez, C. ;
Duenwald, S. ;
He, Y. ;
Raymond, V. ;
Faull, I. ;
Buron, A. ;
Alvarez-Urturi, C. ;
Castells, X. ;
Bellosillo, B. ;
Montagut, C. .
ANNALS OF ONCOLOGY, 2023, 34 (12) :1187-1193
[9]   Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study):: influence of microsatellite instability status and country of origin [J].
Bishehsari, F. ;
Mahdavinia, M. ;
Malekzadeh, R. ;
Verginelli, F. ;
Catalano, T. ;
Sotoudeh, M. ;
Bazan, V. ;
Agnese, V. ;
Esposito, D. L. ;
De Lellis, L. ;
Semeraro, D. ;
Colucci, G. ;
Hormazdi, M. ;
Rakhshani, N. ;
Cama, A. ;
Piantelli, M. ;
Iacobelli, S. ;
Russo, A. ;
Mariani-Costantini, R. .
ANNALS OF ONCOLOGY, 2006, 17 :VII91-VII96
[10]   Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study [J].
Briggs, Sarah E. W. ;
Law, Philip ;
East, James E. ;
Wordsworth, Sarah ;
Dunlop, Malcolm ;
Houlston, Richard ;
Hippisley-Cox, Julia ;
Tomlinson, Ian .
BMJ-BRITISH MEDICAL JOURNAL, 2022, 379